Stockscreener 앱 받기
4.20
18.98%
0.67
시장 영업 전:
4.55
0.35
+8.33%
전일 마감가:
$3.53
열려 있는:
$3.79
하루 거래량:
770.43K
Relative Volume:
19.04
시가총액:
$64.59M
수익:
$52.55M
순이익/손실:
$-23.69M
주가수익비율:
-2.0792
EPS:
-2.02
순현금흐름:
$-15.29M
1주 성능:
+52.73%
1개월 성능:
+45.83%
6개월 성능:
+124.60%
1년 성능:
+169.23%
1일 변동 폭
$3.30
$4.23
1주일 범위
$2.72
$4.23
52주 변동 폭
$1.3003
$4.23
Exagen Inc Stock (XGN) Company Profile
명칭
Exagen Inc
전화
(760) 560-1501
주소
1261 LIBERTY WAY, VISTA, CA
XGN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| XGN | 4.20 | 64.59M | 52.55M | -23.69M | -15.29M | -2.02 |
| TMO | 512.84 | 195.55B | 42.37B | 6.14B | 7.78B | 15.26 |
| DHR | 233.10 | 166.92B | 23.74B | 3.89B | 4.98B | 7.93 |
| A | 128.57 | 36.94B | 6.50B | 1.41B | 1.42B | 3.82 |
| IQV | 194.38 | 35.03B | 15.32B | 1.41B | 1.96B | 5.95 |
| IDXX | 418.61 | 33.80B | 3.84B | 866.24M | 792.60M | 9.80 |
Exagen Inc Stock (XGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-08-05 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-04-15 | 개시 | Canaccord Genuity | Buy |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-10-08 | 개시 | BTIG Research | Buy |
| 2020-06-02 | 재개 | Cantor Fitzgerald | Overweight |
| 2019-10-14 | 개시 | Cantor Fitzgerald | Overweight |
| 2019-10-14 | 개시 | Cowen | Outperform |
| 2019-10-14 | 개시 | William Blair | Outperform |
모두보기
Exagen Inc 주식(XGN)의 최신 뉴스
Exagen CEO, President & Director Acquires 7.7% More Stock - Simply Wall St
Exagen stock soars to 52-week high, hits $3.79 By Investing.com - Investing.com South Africa
Exagen stock soars to 52-week high, hits $3.79 - Investing.com India
Exagen CFO Jeffrey Black acquires $66,448 in common stock - Investing.com India
Exagen president and CEO John Aballi buys $68,297 in stock - Investing.com
What is William Blair’s Forecast for Exagen FY2024 Earnings? - Defense World
Research Analysts Issue Forecasts for Exagen FY2024 Earnings - MarketBeat
FY2024 EPS Estimates for Exagen Raised by Cantor Fitzgerald - MarketBeat
Cantor Fitzgerald Increases Earnings Estimates for Exagen - Defense World
Exagen Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
William Blair Reiterates “Outperform” Rating for Exagen (NASDAQ:XGN) - Defense World
Exagen unveils new biomarkers to enhance autoimmune testing - Investing.com
Exagen Inc. Completes Validation and Regulatory Submission - GlobeNewswire
Exagen Enhances AVISE CTD Platform with 7 New Biomarkers for Autoimmune Disease Detection | XGN Stock News - StockTitan
Exagen Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Exagen Inc. to Participate in Fourth Quarter Investor Conferences - The Manila Times
Exagen stock holds Sector Weight amid mixed 3Q24 results - Investing.com India
Exagen CEO to Present at Three Major Healthcare Investor Conferences | XGN Stock News - StockTitan
Exagen (NASDAQ:XGN) Receives Outperform Rating from William Blair - MarketBeat
Exagen Inc. (NASDAQ:XGN) Q3 2024 Earnings Call Transcript - Insider Monkey
Exagen Inc (XGN) Q3 2024 Earnings Call Highlights: Navigating Ch - GuruFocus.com
Exagen Inc (XGN) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic Growth ... - Yahoo Finance
Exagen Inc. Reports Q3 2024 Financial Results - TipRanks
Exagen Inc. (XGN) Quarterly 10-Q Report - Quartzy
Exagen Inc. (XGN) Reports Q3 Loss, Misses Revenue Estimates - MSN
Exagen stock holds Sector Weight amid mixed 3Q24 results By Investing.com - Investing.com UK
Exagen Inc (XGN) Q3 2024 Earnings: Revenue Misses Estimates at $12.5M, Net Loss Narrows to $5.0M - GuruFocus.com
Exagen Inc. Reports Third Quarter 2024 Results - GlobeNewswire
Exagen Q3 Revenue Hits $12.5M Despite Setbacks; YTD Performance Shows 37% Loss Reduction | XGN Stock News - StockTitan
Exagen Inc (XGN) Q3 2024 Earnings Report Preview: What To Expect - GuruFocus.com
Exagen (XGN) to Release Earnings on Tuesday - Defense World
Exagen to Announce Third Quarter 2024 Results on November 12, 2024 - GlobeNewswire
Exagen Announces Acceptance of Five Abstracts at 2024 American College of Rheumatology Convergence - The Manila Times
Renaissance Technologies LLC Boosts Holdings in Exagen Inc. (NASDAQ:XGN) - Defense World
Exagen Insider Stock Sales Prove Timely As Market Valuation Descends To US$47m - Simply Wall St
Stonepine Capital Management LLC Has $653,000 Holdings in Exagen Inc. (NASDAQ:XGN) - Defense World
Exagen Inc. (NASDAQ:XGN) Shares Sold by Nantahala Capital Management LLC - Defense World
Exagen's SWOT analysis: diagnostic firm's stock poised for growth amid challenges - Investing.com
Exagen Inc. (NASDAQ:XGN) Short Interest Up 20.9% in September - MarketBeat
Octopus Energy acquires solar and storage company Exagen Group - Yahoo Finance
Octopus buys British solar and battery storage firm Exagen - Reuters
PARP Inhibitor Biomarkers Market Expected to Reach $1.75 Billion by 2031 - WhaTech
Autoimmune Disease Diagnostics Market 2024 Global Insights and Business Scenario 2031 - Newstrail
San Diego 2024 Top Tech Awards ceremony set for Sept. 26 at Snapdragon Stadium - CBS News 8
Autoimmune Disease Testing Market to Reach $12.1 Billion, Globally, by 2033 at 8.6% CAGR: Allied Market Research - PR Newswire UK
Bears are Losing Control Over Exagen (XGN), Here's Why It's a 'Buy' Now - MSN
Shareholders in Exagen (NASDAQ:XGN) have lost 84%, as stock drops 12% this past week - Yahoo Finance
PARP Inhibitor Biomarkers Market to Surge with 8.8% CAGR by 2031 - WhaTech
Improved Revenues Required Before Exagen Inc. (NASDAQ:XGN) Stock's 40% Jump Looks Justified - Simply Wall St
Exagen Inc. to Participate in the 2024 Cantor Global Healthcare Conference - ForexTV.com
Exagen Inc (XGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.69%
2.46%
자본화:
|
볼륨(24시간):